BVT Aktienanleihe AMD 28.03.2025/ DE000VD2UAF2 /
7/8/2024 7:55:31 PM | Chg.+0.630 | Bid9:59:53 PM | Ask9:59:53 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
98.320EUR | +0.64% | - Bid Size: - |
- Ask Size: - |
ADVANCED MIC.DEV. D... | 160.00 - | 3/28/2025 | Call |
GlobeNewswire
6/27
Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Supracho...
GlobeNewswire
6/26
EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulat...
GlobeNewswire
6/24
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
6/19
AMD to Power AI-Based Smart Parking Solution for Sun Singapore, the Country’s Largest Provider of Sm...
GlobeNewswire
6/18
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
6/17
D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
GlobeNewswire
6/14
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire
6/13
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire
6/13
Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire
6/12
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
6/12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
6/12
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...